Samsung India set to transform patient-centric imaging with new mobile CT technologies portfolio

New Delhi: Samsung in collaboration with NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd., has announced the launch of its next-generation mobile CT product portfolio in India.

Samsung Electronics Co., Ltd. is a global leader in advanced medical imaging technologies. Specifically designed to transform diagnostic and interventional radiology in India, these next-generation systems combine mobility, AI-powered efficiency, and patient-first design, ultimately empowering healthcare providers to deliver quality care anytime, anywhere.

The newly introduced range includes CereTom® Elite, OmniTom® Elite, OmniTom® Elite PCD, and BodyTom® 32/64, each tailored to meet the diverse clinical needs of hospitals and specialty centres. By enabling adoption across hospitals of all sizes, including those in underserved regions, Samsung is set to help democratise access to advanced imaging in India.

“Samsung is taking a decisive step toward making advanced medical imaging more accessible, efficient, and patient-centric with the launch of the mobile CT solutions in India. These innovations are as much about technology as they are about empowering healthcare providers to bridge the care gap between metros and tier-2/3 cities. We believe this portfolio will strengthen India’s healthcare infrastructure, support clinical excellence across specialties, and play a crucial role in improving patient outcomes at scale,” said Atantra Das Gupta, Head of HME Business, Samsung India.